These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin].
    Author: Wenderoth UK, Jacobi GH.
    Journal: Ann Urol (Paris); 1986; 20(2):95-7. PubMed ID: 3087269.
    Abstract:
    Patients with metastatic prostatic cancer were treated by means of an LHRH agonist, Buserelin, by nasal administration. The serum testosterone levels were permanently decreased to castration levels in all patients. The objective response rate (CR + PR) was 50%.
    [Abstract] [Full Text] [Related] [New Search]